These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries? Abud-Mendoza C; Martínez-Martínez MU; DE Jesús Macías-Mendoza J; Magaña-Aquino M J Rheumatol; 2010 Mar; 37(3):672-3; author reply 673. PubMed ID: 20197567 [No Abstract] [Full Text] [Related]
6. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial. Park JH; Seo GY; Lee JS; Kim TH; Yoo DH J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901 [TBL] [Abstract][Full Text] [Related]
7. Disseminated tuberculosis secondary to adalimumab. Pednekar M; Chandra AB; Chandra PA Am J Ther; 2012 Jul; 19(4):e139-40. PubMed ID: 20838203 [TBL] [Abstract][Full Text] [Related]
8. Tuberculosis infections and tumor necrosis factor alpha antagonists. Gan J; Manadan AM; Sequiera W; Block JA Am J Ther; 2013 Jan; 20(1):73-8. PubMed ID: 21519217 [TBL] [Abstract][Full Text] [Related]
9. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis. Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305 [TBL] [Abstract][Full Text] [Related]
10. Erythema nodosum, a "red flag" during anti-TNF therapy. Dalmau-Carolà J Int J Rheum Dis; 2013 Aug; 16(4):493-4. PubMed ID: 23992277 [No Abstract] [Full Text] [Related]
11. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents. Doherty SD; Van Voorhees A; Lebwohl MG; Korman NJ; Young MS; Hsu S; National Psoriasis Foundation J Am Acad Dermatol; 2008 Aug; 59(2):209-17. PubMed ID: 18485527 [TBL] [Abstract][Full Text] [Related]
12. [Screening for tuberculosis before TNFα treatment in routine rheumatic care in Iceland. Result from the nationwide ICEBIO registry]. Bjorgulfsson TM; Gröndal G; Blondal T; Gudbjornsson B Laeknabladid; 2018 Mai; 104(5):231-235. PubMed ID: 29717989 [TBL] [Abstract][Full Text] [Related]
13. Malignancies developing in obese patients with psoriasis while on antitumour necrosis factor-α therapies: a case series. Sadlier M; Lally A; Kirby B Br J Dermatol; 2012 Oct; 167(4):937-8. PubMed ID: 22428935 [No Abstract] [Full Text] [Related]
14. New challenges for the pulmonologist in the diagnosis of latent tuberculosis infection: biological treatment and pulmonary tuberculosis. Hernández González F; Sanz Herrero F; Lloret Pérez T Arch Bronconeumol; 2011 Jul; 47(7):375. PubMed ID: 21440975 [No Abstract] [Full Text] [Related]
15. Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis. Guidelli GM; Tenti S; Fioravanti A Indian J Dermatol Venereol Leprol; 2014; 80(2):187-9. PubMed ID: 24685874 [No Abstract] [Full Text] [Related]
16. Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritis. Sanduzzi A; Bocchino M; Atteno M; Costa L; Ponticiello A; Matarese A; Spanò A; Bruner V; Peluso R; Aquino MM; Del Puente A; Scarpa R J Rheumatol Suppl; 2012 Jul; 89():82-5. PubMed ID: 22751601 [TBL] [Abstract][Full Text] [Related]
17. Unaffected reaction level in tuberculin skin test by long-term therapy with tumor necrosis factor inhibitors for rheumatoid arthritis. Yamamoto S; Nagatani K; Sato T; Iwamoto M; Takatori S; Minota S Int J Rheum Dis; 2017 May; 20(5):584-588. PubMed ID: 28524434 [TBL] [Abstract][Full Text] [Related]
18. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report. Malaviya AN; Kapoor S; Garg S; Rawat R; Shankar S; Nagpal S; Khanna D; Furst DE J Rheumatol; 2009 Jul; 36(7):1414-20. PubMed ID: 19487263 [TBL] [Abstract][Full Text] [Related]
19. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?]. Schmutz JL; Trechot P Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389 [No Abstract] [Full Text] [Related]